U.S. Banks Stock News

NYSE:TFX
NYSE:TFXMedical Equipment

Is Teleflex (TFX) Pricing Look Attractive After Recent Share Price Weakness

If you are wondering whether Teleflex's current share price reflects its true worth, this breakdown will help you see how the market price lines up with several valuation checks. The stock recently closed at US$120.27, with returns of 2.1% over the last week and 7.5% over the last month, while year to date it is down 1.7% and the 1 year return is a 5.7% decline. These mixed returns sit against a backdrop of ongoing attention on Teleflex as a medical equipment company, with investors weighing...
NYSE:LH
NYSE:LHHealthcare

Labcorp Expands Specialized Testing As AI Efficiencies Shape Valuation Story

Labcorp Holdings, NYSE:LH, is expanding into specialized diagnostic testing, including oncology and neurology, through recent acquisitions and product launches. The company is reporting operational improvements and cost savings linked to business optimization and AI driven initiatives. These changes reflect a sharpened focus on higher growth testing segments and more efficient operations. Labcorp Holdings, NYSE:LH, enters this phase of expansion with its shares at $273.26 and a 26.3% return...
NasdaqCM:BYRN
NasdaqCM:BYRNAerospace & Defense

Byrna Technologies (BYRN) Net Margin Drop Challenges Bullish Growth Narratives Ahead Of Q1 2026

Byrna Technologies (BYRN) has just opened its Q1 2026 earnings season narrative following a Q4 2025 print that showed total revenue of US$35.2 million and basic EPS of US$0.15, with trailing twelve month revenue at US$118.1 million and basic EPS of US$0.43. Over recent quarters the company has seen revenue move from US$27.9 million in Q4 2024 to US$35.2 million in Q4 2025, while basic EPS shifted from US$0.43 to US$0.15. This sets up a results story where investors are likely to focus on how...
NasdaqGS:RGP
NasdaqGS:RGPProfessional Services

Resources Connection (RGP) Quarterly Loss Narrows Challenging Bearish Profitability Narratives

Resources Connection (RGP) has reported Q3 2026 revenue of US$107.9 million alongside a basic EPS loss of US$0.28, with trailing 12 month EPS at a loss of US$2.94 on revenue of US$485.2 million. The company has seen quarterly revenue move from US$145.6 million in Q2 2025 to US$129.4 million in Q3 2025 and then to US$107.9 million in Q3 2026. Over the same period, quarterly EPS moved from a loss of US$2.08 in Q2 2025 to a loss of US$1.34 in Q3 2025 and then to a loss of US$0.28 in Q3 2026,...
NasdaqGS:CSWC
NasdaqGS:CSWCCapital Markets

Is Capital Southwest (CSWC) Pricing In Too Much Optimism After Strong 1 Year Run?

If you are wondering whether Capital Southwest at around US$22.67 is priced for opportunity or already reflects the story you are paying for, this breakdown will help you frame what the current share price might be implying. Over shorter periods, the stock has returned 1.3% over 7 days and 3.1% over 30 days, with returns of 1.7% year to date and 34.6% over 1 year. The 3 year and 5 year figures sit at 74.0% and 69.2% respectively. Recent news flow around Capital Southwest has largely focused...
NYSE:VIRT
NYSE:VIRTCapital Markets

Is It Time To Reassess Virtu Financial (VIRT) After Its Strong Recent Share Price Run?

If you are considering Virtu Financial at around US$49.66 and wondering whether it offers value or requires paying a premium for quality, this breakdown can help you clarify that question before committing fresh capital. The stock has posted returns of 7.4% over 7 days, 21.0% over 30 days, 52.3% year to date and 43.1% over 1 year, with a 3 year return of 188.3% and a 5 year return of 91.7%. These figures naturally raise questions about how the current price compares with the company’s...
NasdaqGS:SKWD
NasdaqGS:SKWDInsurance

Is Skyward Specialty Insurance Group (SKWD) Pricing Reflect Its Recent Share Price Slide And Volatility

If you are wondering whether Skyward Specialty Insurance Group at around US$45.89 is offering fair value or a potential bargain, this article will help you put the current share price in context. The stock has risen 4.5% over the last 7 days, while returns sit at a 0.9% decline over 30 days, a 5.6% decline year to date and a 12.0% decline over the past year, compared with a very large 3-year return of 117.7%. Recent coverage has focused on Skyward Specialty Insurance Group's role within the...
NasdaqGM:KDK
NasdaqGM:KDKAuto Components

Is Kodiak AI (KDK) Pricing Reflect Future Cash Flow Potential After Recent Share Price Slide

Wondering if Kodiak AI at US$7.85 is a bargain or a value trap? This article walks through what the current price could be saying about the stock. The share price has moved 9.0% over the last 7 days, after a 9.5% decline over 30 days and a 27.5% fall year to date, with the 1 year return at 29.7% in the red. Recent coverage has focused on Kodiak AI as part of broader discussions about listed auto related and AI exposed names, with investors weighing business potential against ongoing...
NasdaqGS:PAA
NasdaqGS:PAAOil and Gas

Canadian Review And FERC Ruling Shape Plains All American Cash Flows

The Canadian Competition Bureau has escalated its review of Keyera's proposed purchase of Plains All American Pipeline's Canadian NGL business, adding more regulatory scrutiny to the transaction. Separately, Plains All American Pipeline received Federal Energy Regulatory Commission approval for its proposed accounting treatment related to the Cactus III pipeline acquisition. These developments affect Plains All American Pipeline's asset mix and the timing of its planned shift toward more fee...
NYSE:TPC
NYSE:TPCConstruction

Tutor Perini (TPC) Valuation Check After Strong Recent Share Price Momentum

Tutor Perini (TPC) has been drawing investor attention after recent share price moves, with the stock showing double digit total returns over the past year and past 3 months. This has prompted closer scrutiny of its fundamentals. See our latest analysis for Tutor Perini. Recent trading has been strong, with a 14.3% 1 month share price return and a 17.5% year to date share price return, alongside a very large 1 year total shareholder return that points to building momentum from earlier...
NYSE:BAH
NYSE:BAHProfessional Services

Booz Allen Backs Portal Space To Deepen Space And Defense Focus

Booz Allen Ventures, the venture arm of Booz Allen Hamilton Holding (NYSE:BAH), has invested in space technology company Portal Space Systems. The partnership focuses on rapidly maneuverable spacecraft aimed at next generation orbital operations and warfare capabilities. The move expands Booz Allen’s exposure to the space and defense sector beyond its core consulting, analytics, and cybersecurity work. For you as an investor, this indicates that NYSE:BAH is putting more focus on space as a...
NasdaqGS:PAYP
NasdaqGS:PAYPDiversified Financial

Is It Time To Reconsider PayPay (PAYP) After Recent Share Price Pullback?

If you are wondering whether PayPay's current share price reflects its true worth, this breakdown will help you size up what you are actually paying for. After closing at US$20.36, the stock has seen a 3.6% decline over the last 7 days while still showing a 12.1% gain year to date, which can change how investors see both risk and opportunity. Recent coverage around PayPay has focused on its position in the diversified financials space and how its business profile fits into broader market...
NasdaqGS:CRUS
NasdaqGS:CRUSSemiconductor

Is It Too Late To Consider Cirrus Logic (CRUS) After Its Strong Share Price Run?

Wondering if Cirrus Logic at around US$154.82 is giving you fair value or asking too much for its growth story? This article breaks that question down in plain terms. The stock has shown strong recent returns, with 5.2% over 7 days, 15.6% over 30 days, 29.4% year to date, 71.6% over 1 year, 73.4% over 3 years, and 84.2% over 5 years, which naturally raises questions about how much optimism is already in the price. Recent coverage has focused on Cirrus Logic as part of wider discussions...
NYSE:DV
NYSE:DVMedia

Is It Time To Reconsider DoubleVerify (DV) After Its 24.5% Share Price Slide?

If you are wondering whether DoubleVerify Holdings is attractively priced or still too expensive, this breakdown will help you frame the current share price against what you might actually be paying for. The stock last closed at US$10.09, with returns of 3.2% over the past week, a 6.6% decline over the past month, and a 24.5% decline over the past year, which may have changed how the market is viewing its risk and reward trade off. Recent coverage has focused on DoubleVerify Holdings as an...
NYSE:TE
NYSE:TEElectrical

Is It Time To Reassess T1 Energy (TE) After Its Sharp Share Price Swings

If you are wondering whether T1 Energy at US$4.17 is starting to look attractive or still carries hidden risks, the key is to line up its price against a few clear valuation checks. The share price has seen sharp swings, with a 253.4% return over the last year, while more recent periods show a 6.9% decline over 7 days, a 41.8% decline over 30 days, and a 46.8% decline year to date. Recent moves have put T1 Energy back on many watchlists, as investors reassess what the latest price action...
NYSE:IFF
NYSE:IFFChemicals

How Investors Are Reacting To International Flavors & Fragrances (IFF) Expanding Microbiome and Soy Protein Health Claims

In early April 2026, International Flavors & Fragrances launched PureStrong, a single-strain canine probiotic, and gained Australia–New Zealand approval for a heart health claim on isolated soy protein, expanding its science-backed pet and human nutrition offerings. These developments highlight how IFF is using microbiome research and regulatory-backed soy protein science to deepen its presence in health-oriented, higher-value specialty ingredients across both pet care and food...
NasdaqGS:EA
NasdaqGS:EAEntertainment

EA SPORTS Gen Platform Links Young Athletes To EA Growth Story

EA SPORTS has launched GEN / EA SPORTS, a new platform focused on connecting emerging athletes and fans through content and culture. The company signed high school athlete Elijah Haven as its first official ambassador, a first for the brand. The move signals EA SPORTS' intent to invest in younger talent and deepen its role across sports and entertainment communities. For investors watching Electronic Arts, NasdaqGS:EA, this launch comes with the stock trading at $203.99 and a 1 year return...
NYSE:DRI
NYSE:DRIHospitality

Strong Q3 Beat and Insider Selling Could Be A Game Changer For Darden Restaurants (DRI)

Darden Restaurants recently reported fiscal third-quarter 2026 results that exceeded expectations, with management highlighting strong same-restaurant sales and an upbeat outlook on March performance. A series of executive share sales, including transactions by Group President Melvin John Martin and SVP Lindsay L. Koren, came alongside more optimistic commentary from analysts who raised their longer-term growth assumptions for the business. With third-quarter earnings topping expectations...
NYSE:CMC
NYSE:CMCMetals and Mining

Is Profit Turnaround And Aggressive Buyback Altering The Investment Case For Commercial Metals (CMC)?

In March 2026, Commercial Metals Company reported past second-quarter sales of US$2,132.02 million and net income of US$93.03 million, alongside six-month sales of US$4,252.33 million and net income of US$270.31 million, marking a clear turnaround from the prior year’s loss. Over the same period, the company also advanced its capital return efforts by completing a share repurchase of 15,131,239 shares for US$702.21 million, shrinking its share count and signaling confidence in its financial...
NasdaqCM:LQDA
NasdaqCM:LQDAPharmaceuticals

Liquidia’s L606 Puts New Focus On Pulmonary Hypertension Growth Story

Liquidia (NasdaqCM:LQDA) is drawing attention after its investigational drug L606 was highlighted as a potential transformative therapy in the interstitial lung disease market. The candidate targets patients facing pulmonary hypertension and related conditions, positioning L606 as a possible new standard of care if clinical development progresses successfully. For investors tracking biopharma, Liquidia focuses on therapies for pulmonary hypertension and related respiratory conditions, an...
NYSE:MCK
NYSE:MCKHealthcare

McKesson CFO Transition Puts Capital Allocation And Valuation In Focus

McKesson (NYSE:MCK) announced that EVP and CFO Britt Vitalone will retire. Kenny Cheung has been named incoming CFO, effective May 29, 2026. The transition shifts responsibility for McKesson's financial leadership and capital decisions to Cheung on that date. For investors watching McKesson at a share price of $871.18, this CFO change comes after a 1 year return of 30.2% and a 5 year gain of about 4.7x. The company has also recorded a 3 year return of 143.7%, while year to date performance...
NYSE:FDS
NYSE:FDSCapital Markets

New FactSet CFO Appointment Coincides With AI Push And Valuation Gap

FactSet Research Systems (NYSE:FDS) has appointed Joshua B. Warren as its new Chief Financial Officer, marking a key executive transition. The leadership change comes as FactSet rolls out new AI powered banking solutions and deepens its partnership with Finster AI. FactSet enters this CFO transition with NYSE:FDS trading at $222.97 and multi year returns that have been under pressure, including a 47.0% decline over the past year and a 24.2% decline over five years. For readers, that...
NasdaqGS:ALMS
NasdaqGS:ALMSPharmaceuticals

How Investors Are Reacting To Alumis (ALMS) Psoriasis Drug’s Strong Phase 3 Data And Safety Profile

Alumis Inc. recently reported Phase 3 ONWARD1 and ONWARD2 data showing its oral TYK2 inhibitor envudeucitinib produced high rates of robust, durable skin clearance and quality-of-life improvements in adults with moderate-to-severe plaque psoriasis through Week 24, with a generally well-tolerated safety profile. An interesting aspect for investors is envudeucitinib’s maximal 24-hour TYK2 inhibition without fasting requirements, aiming to balance efficacy, convenience, and selective immune...
NasdaqGM:NMIH
NasdaqGM:NMIHDiversified Financial

Will NMI Holdings’ US$250 Million Buyback Through 2027 Change NMIH’s Investment Narrative?

NMI Holdings recently announced a US$250.00 million share repurchase program running through December 2027, following a period of consistent earnings outperformance and solid operating results that have strengthened investor confidence. This combination of disciplined capital returns and robust fundamental execution underscores management’s focus on enhancing shareholder value while reinforcing the company’s position in the private mortgage insurance market. With this sizeable buyback plan...